OneSource Specialty Pharma Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 30.47% of OneSource Specialty Pharma, FIIs hold 19.45%, DIIs hold 24.20% and the public holds 25.86%. Promoter holding fell by 0.01 percentage points from Jun 2026.

Get an alert when OneSource Specialty Pharma reports results or its shareholding changes. Free account.

Promoters

30.47%

−0.01 pp QoQ

FIIs

19.45%

+0.26 pp QoQ

DIIs

24.20%

+0.83 pp QoQ

Public

25.86%

−1.09 pp QoQ

OneSource Specialty Pharma shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicShareholders
Sep 202630.47%19.45%24.20%25.86%79,770
Jun 202630.48%19.19%23.37%26.95%77,899
Mar 202630.48%17.50%20.61%31.40%79,460
Dec 202529.93%19.24%18.80%32.01%84,595
Sep 202529.77%19.39%18.48%32.34%87,416
Jun 202529.78%18.69%18.09%33.42%87,760
Mar 202534.25%18.54%18.03%29.17%82,712
Dec 202437.76%17.44%12.56%32.24%98,425

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹18.46k cr, the promoter group's 30.48% stake is worth ₹5.63k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

OneSource Specialty Pharma shareholding: common questions

What is the promoter holding in OneSource Specialty Pharma?

Promoters hold 30.47% of OneSource Specialty Pharma as of Sep 2026. Their stake fell by 0.01 percentage points from Jun 2026.

How much do FIIs hold in OneSource Specialty Pharma?

Foreign institutional investors (FIIs) held 19.45% of OneSource Specialty Pharma in Sep 2026, +0.26 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in OneSource Specialty Pharma?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 24.20% of OneSource Specialty Pharma in Sep 2026, +0.83 pp versus Jun 2026.

Is the promoter holding in OneSource Specialty Pharma pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in OneSource Specialty Pharma.

How has OneSource Specialty Pharma's promoter holding changed in the last year?

Promoter holding moved from 29.77% in Sep 2025 to 30.47% in Sep 2026 (+0.70 pp).

How many shareholders does OneSource Specialty Pharma have?

OneSource Specialty Pharma had 79,770 shareholders in Sep 2026, compared with 77,899 in Jun 2026.